Western Pacific Wealth Management »

Regeneron Pharmaceuticals shares owned by Western Pacific Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Western Pacific Wealth Management from 13F filings

Historical chart of Western Pacific Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Western Pacific Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Western Pacific Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $53k 60 878.28
2023-09-30 $60k 73 822.96
2023-06-30 $53k 73 718.53
2023-03-31 $60k 73 821.66

More positions owned by Western Pacific Wealth Management

Nike Inc Cl B Stock (NKE)
Apple Stock (AAPL)
Vanguard Dividend Appreciation Etf Etf (VIG)
Amazon Stock (AMZN)
Vanguard High Dividend Yield Index Etf Etf (VYM)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Nvidia Corporation Stock (NVDA)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Meta Platforms Inc Cl A Stock (META)
Costco Whsl Corp Stock (COST)
Salesforce Stock (CRM)
Palantir Technologies Inc Cl A Stock (PLTR)
Intuitive Surgical Stock (ISRG)

View all positions for Western Pacific Wealth Management

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals